What is the Trelegy Ellipta Inhaler?
Trelegy Ellipta is a unique type of inhaler used for managing and treating chronic obstructive pulmonary disease (COPD). It contains three active ingredients: fluticasone, umeclidinium, and vilanterol. Fluticasone is a type of medicine called a corticosteroid (different from anabolic steroids, it helps relieve swelling and inflammation), while umeclidinium and vilanterol are bronchodilators (which open up your airways so you can breathe easier) This combination of corticosteroids and bronchodilators works directly in the lungs, where they relieve symptoms of COPD such as coughing, wheezing and difficulty breathing.
COPD makes the muscles around your airways tighten, making it difficult to breathe. Fluticasone furoate is a steroid that reduces inflammation in the airways, and umeclidinium is a long-acting anticholinergic drug that relaxes the muscles in the airways, making it easier to breathe. And lastly, vilanterol is a long-acting beta-2 agonist that opens up the airways to improve breathing.
Trelegy Ellipta should be taken every day to manage the symptoms of COPD, rather than to relieve sudden attacks of breathlessness and wheezing. For these you should use a fast-acting reliever inhaler.
How does Trelegy Ellipta work?
The three active ingredients in Trelegy Ellipta work directly in your lungs to relieve and prevent breathing difficulties. Trelegy Ellipta relaxes muscles in the lungs, reduces swelling and irritation in the airways and makes it easier for air to get in and out of the lungs.[1]
Fluticasone furoate is a corticosteroid used for its anti-inflammatory properties. It works similarly to natural corticosteroid hormones, preventing the immune system from releasing chemicals that cause inflammation. By reducing inflammation, irritation and swelling, this keeps the airways clear – making it easier to breathe.
Umeclidinium is a long-acting muscarinic antagonist (LAMA), or anticholinergic. It works by blocking certain receptors in the airways that cause smooth muscles to contract and tighten, stopping them from constricting.
Vilanterol is a long-acting beta-2 agonist (LABA). It‘s a bronchodilator that activates the beta-2 receptors of muscle cells in the airways and relaxes the muscles around them so the airways stay open. This makes it easier for air to pass in and out of your lungs.[2]
Who is Trelegy Ellipta for?
Trelegy Ellipta is for adults with moderate to severe COPD who need a combination treatment of an inhaled corticosteroid, long-acting beta-2 agonist bronchodilator and long-acting muscarinic bronchodilator.
What doses does Trelegy Ellipta come in?
Trelegy Ellipta Inhaler uses three active ingredients that come in this dosage:
- 92 mcg of fluticasone
- 55 mcg of umeclidinium
- 22 mcg of vilanterol
This is written as 92/55/22 mcg. Each inhaler contains 30 puffs. You can also get inhalers that contain 60 or 90 puffs (doses).
How we source info.
When we present you with stats, data, opinion or a consensus, we’ll tell you where this came from. And we’ll only present data as clinically reliable if it’s come from a reputable source, such as a state or government-funded health body, a peer-reviewed medical journal, or a recognised analytics or data body. Read more in our editorial policy.